NO942307D0 - New BHT Ether Compounds and Their Use as Hypolipidemic and Anti-Atherosclerotic Drugs - Google Patents

New BHT Ether Compounds and Their Use as Hypolipidemic and Anti-Atherosclerotic Drugs

Info

Publication number
NO942307D0
NO942307D0 NO942307A NO942307A NO942307D0 NO 942307 D0 NO942307 D0 NO 942307D0 NO 942307 A NO942307 A NO 942307A NO 942307 A NO942307 A NO 942307A NO 942307 D0 NO942307 D0 NO 942307D0
Authority
NO
Norway
Prior art keywords
hypolipidemic
ether compounds
atherosclerotic drugs
new
new bht
Prior art date
Application number
NO942307A
Other languages
Norwegian (no)
Other versions
NO301473B1 (en
NO942307L (en
Inventor
Markus R Gold
Panayiotis Jarglis
Heinz Junglas
Jurgen H Leimner
Dezsoe Peteri
Gunter P Quack
Josef Strohmeier
Petra M Wulfroth
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of NO942307D0 publication Critical patent/NO942307D0/en
Publication of NO942307L publication Critical patent/NO942307L/en
Publication of NO301473B1 publication Critical patent/NO301473B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO942307A 1991-12-19 1994-06-17 BHT-omega-pyridyl ether compounds and pharmaceutical compositions containing them NO301473B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/810,214 US5254549A (en) 1991-12-19 1991-12-19 New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
PCT/EP1992/002946 WO1993012089A1 (en) 1991-12-19 1992-12-18 New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs

Publications (3)

Publication Number Publication Date
NO942307D0 true NO942307D0 (en) 1994-06-17
NO942307L NO942307L (en) 1994-06-17
NO301473B1 NO301473B1 (en) 1997-11-03

Family

ID=25203281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942307A NO301473B1 (en) 1991-12-19 1994-06-17 BHT-omega-pyridyl ether compounds and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US5254549A (en)
EP (1) EP0619807A1 (en)
JP (1) JPH07502271A (en)
AU (1) AU662193B2 (en)
CA (1) CA2085687A1 (en)
CZ (1) CZ283456B6 (en)
FI (1) FI942908A0 (en)
HU (1) HU215844B (en)
IL (1) IL104123A (en)
MX (1) MX9207427A (en)
NO (1) NO301473B1 (en)
PL (1) PL171225B1 (en)
RU (1) RU2120938C1 (en)
TW (1) TW221289B (en)
WO (1) WO1993012089A1 (en)
ZA (1) ZA929867B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US5627172A (en) * 1994-03-04 1997-05-06 Natural Supplement Association, Incorporated Method for reduction of serum blood lipids or lipoprotein fraction
US5795876A (en) * 1996-04-30 1998-08-18 Hoechst Marion Rousssel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
US5608095A (en) * 1996-04-30 1997-03-04 Hoechst Marion Roussel, Inc. Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
US6121463A (en) * 1997-06-24 2000-09-19 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
US6475526B1 (en) 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
US20080274209A1 (en) * 2002-11-04 2008-11-06 Integritas Pharma, Inc. Methods of treating inflammation
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE271625C (en) *
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives
DE3431004A1 (en) * 1984-08-23 1986-03-06 Hoechst Ag, 6230 Frankfurt NEW 3-PYRIDYL COMPOUNDS AND METHOD FOR THEIR PRODUCTION

Also Published As

Publication number Publication date
WO1993012089A1 (en) 1993-06-24
HU215844B (en) 1999-04-28
CZ283456B6 (en) 1998-04-15
NO301473B1 (en) 1997-11-03
PL171225B1 (en) 1997-03-28
FI942908A (en) 1994-06-17
FI942908A0 (en) 1994-06-17
IL104123A0 (en) 1993-05-13
US5254549A (en) 1993-10-19
CZ135294A3 (en) 1995-11-15
CA2085687A1 (en) 1993-06-20
RU2120938C1 (en) 1998-10-27
ZA929867B (en) 1994-06-20
JPH07502271A (en) 1995-03-09
NO942307L (en) 1994-06-17
AU662193B2 (en) 1995-08-24
IL104123A (en) 1996-12-05
AU3159293A (en) 1993-07-19
EP0619807A1 (en) 1994-10-19
HUT70398A (en) 1995-10-30
MX9207427A (en) 1993-11-01
TW221289B (en) 1994-02-21
HU9401820D0 (en) 1994-09-28

Similar Documents

Publication Publication Date Title
NO304074B1 (en) New steroid esters, pharmaceutical preparations containing these compounds and their use
NO304073B1 (en) New steroids, pharmaceutical preparations containing these compounds and their use
NO922506L (en) PHARMACEUTICAL PREPARATIONS
NO921958L (en) PHARMACEUTICAL PREPARATION
NO922006L (en) PHARMACEUTICAL PREPARATION
NO307707B1 (en) Spiroazabicyclic compounds, pharmaceutical preparations containing such compounds and their use
NO982802L (en) New 5-amino-3-cyano-4-ethylsulfinyl-1-phenyl-pyrazole compounds and their use as pesticides
FI934914A (en) PHARMACEUTICAL FORMULATION
DK0524482T3 (en) Substituted triazoles and their use as herbicides
NO308533B1 (en) Heteroarlamines, their use and pharmaceutical composition
NO952677D0 (en) New dihydropyrrolopyridinone and oxazolopyridinone compounds, their preparation and pharmaceutical preparations
NO303446B1 (en) New 2-saccharinylmethylaryl and aryloxyacetates, preparations and use thereof
NO934372D0 (en) New compounds and pharmaceutical preparations thereof
NO933425D0 (en) NEW ACTIVE RELATIONSHIPS
NO942307D0 (en) New BHT Ether Compounds and Their Use as Hypolipidemic and Anti-Atherosclerotic Drugs
DK155292D0 (en) CHEMICAL COMPOUNDS, THEIR PREPARATION AND USE
NO983678D0 (en) New cephemic compounds and pharmaceutical applications thereof
NO305953B1 (en) New (1-phenyl-1-hydrocyclyl) methanol and (1-phenyl-heterocyclyl) methylamine derivatives, pharmaceutical preparations containing such derivatives and their use
NO941479D0 (en) New drug formulations containing ion exchangers
DK73091D0 (en) QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE
NO921908D0 (en) AMINOSYRAZETIDINYL SUBSTITUTED PYRIDON DERIVATIVES, THEIR PREPARATION AND USE AS MEDICINES
NO179073C (en) Imide-terminated polynitrogen compounds, their preparation and use
NO921723D0 (en) NEW QUINOL COMPOUNDS, THE PROCEDURE FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE
NO942322D0 (en) New 3-halogen-5-halomethyl-2-oxazolidinones and their use as microbicides
ITRM920415A1 (en) COMPOSITION FOR SURGICAL USE AND ITS APPLICATIONS FOR SURGICAL IRRIGATIONS.